Despite the fact that more than half the European student population is female, women hold less then 15% of full professorships in Europe, according to the She Figures 2006 from the European Commission. While the percentage of female university graduates and PhD holders has increased, the gender gap is not closing at the same rate as careers advance.
The study authors, Ledin, Bornmann, Gannon and Wallon, were prompted to investigate whether gender bias was at the root of the lower success rate of female applicants to the EMBO Long-Term Fellowship and Young Investigator Programmes. Gender blinding of application reviewers found that gender bias was not the cause. A thorough investigation of the publication data of all applicants revealed that the performance gap widens even further between men and women researchers at later stages of their careers. This widening gap results in a 50% lower fraction of females applying as young group leaders to the EMBO Young Investigator Programme as compared to the number of female postdoctoral scientists who apply for the EMBO Long-Term Fellowships.
The EMBO Long-Term Fellowship Programme attracts scientists who completed their PhD training within the previous three years before application and are seeking financial support for post-doctoral research. Scientists at a later stage of their careers who are within four years of establishing their first independent laboratories can apply for support through the EMBO Young Investigator Programme.
Surveys of applicants found that traditional gender roles combined with a pervasive negative work culture appeared to be at the root of the lower success rate of women researchers versus men researchers.
The traditional gender roles are manifested by the facts that women take substantially more parental leave and more often adjust their careers in preference to that of their male partners. As a result women publish less and are slower to advance in their careers because on average they spend less time at work and have a greater burden to carry outside of the lab than their male counterparts at the same stage of their careers.
In the workplace, women scientists had fewer opportunities for mentoring, less supervisor support once they began to have families and there was a general lack of gender policy and monitoring in institutions.
The study authors ask whether employers, policy makers, scientists and society can afford to lose such a large number of trained specialists from the workforce. They conclude that both a shift in thinking about the roles of men and women and positive action in the workplace are required to ensure that family decisions do not prevent men and women from career and societal aspirations.
Through its Women In Science Programme, EMBO assesses and acts on imbalances in the scientific career path. EMBO monitors the selection process in EMBO programmes, alerts EMBO committees towards gender imbalance, devises actions to counteract gender imbalance and creates awareness in the scientific community.
The study publication A Persistent Problem: Traditional gender roles hold back female scientists appears online until 30 November 2008 at http://www.nature.com/embor.About EMBO
Leading peer-reviewed journals - The EMBO Journal, EMBO reports and Molecular Systems Biology - span all aspects of molecular biology and reflect how science is shaping the world. EMBO-sponsored training and networking activities impact thousands of scientists every year, promoting collaboration in all areas of molecular biology - within Europe and worldwide. EMBO is renowned for the quality and funding of these programmes and activities that include EMBO Courses & Workshops, EMBO Long-and Short-term Fellowships, the EMBO Young Investigator Programme, the EMBO Science & Society Programme, EMBO Installation Grants and EMBO Women in Science.
Annual awards, such as the EMBO Gold Medal and the EMBO Award for Communication in the Life Sciences, recognise significant contributions of European researchers to the advancement of science.
Suzanne Beveridge | idw
Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel
Smelling the forest – not the trees
12.12.2018 | Universität Konstanz
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine